These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Bacteremia due to Citrobacter braakii: A case report and literature review. Hirai J; Uechi K; Hagihara M; Sakanashi D; Kinjo T; Haranaga S; Fujita J J Infect Chemother; 2016 Dec; 22(12):819-821. PubMed ID: 27553069 [TBL] [Abstract][Full Text] [Related]
30. Isolation and characterization of tetracycline-resistant Citrobacter spp. from catfish. Nawaz M; Khan AA; Khan S; Sung K; Steele R Food Microbiol; 2008 Feb; 25(1):85-91. PubMed ID: 17993380 [TBL] [Abstract][Full Text] [Related]
31. Extended-spectrum β-lactamase-producing Enterobacteriaceae from animal origin and wastewater in Tunisia: first detection of O25b-B2 Sghaier S; Abbassi MS; Pascual A; Serrano L; Díaz-De-Alba P; Said MB; Hassen B; Ibrahim C; Hassen A; López-Cerero L J Glob Antimicrob Resist; 2019 Jun; 17():189-194. PubMed ID: 30639890 [TBL] [Abstract][Full Text] [Related]
32. Clinical Characteristics and Antimicrobial Susceptibility Trends in Lee R; Choi SM; Jo SJ; Lee J; Cho SY; Kim SH; Lee DG; Jeong HS Infect Chemother; 2019 Mar; 51(1):1-9. PubMed ID: 30941932 [TBL] [Abstract][Full Text] [Related]
33. [Characterization and distribution of Citrobacter species in a university hospital]. Manganello S; Tayara A; Perazzi B; Neira L; Famiglietti A; Pugliese L; Santini P; Vay C Enferm Infecc Microbiol Clin; 2001 Jan; 19(1):11-4. PubMed ID: 11256240 [TBL] [Abstract][Full Text] [Related]
34. High prevalence of extended-spectrum β-lactamases and qnr determinants in Citrobacter species from Japan: dissemination of CTX-M-2. Kanamori H; Yano H; Hirakata Y; Endo S; Arai K; Ogawa M; Shimojima M; Aoyagi T; Hatta M; Yamada M; Nishimaki K; Kitagawa M; Kunishima H; Kaku M J Antimicrob Chemother; 2011 Oct; 66(10):2255-62. PubMed ID: 21733965 [TBL] [Abstract][Full Text] [Related]
35. Genetic regulation of variable Vi antigen expression in a strain of Citrobacter freundii. Snellings NJ; Johnson EM; Kopecko DJ; Collins HH; Baron LS J Bacteriol; 1981 Feb; 145(2):1010-7. PubMed ID: 6161917 [TBL] [Abstract][Full Text] [Related]
36. Citrobacter freundii bacteremia: Risk factors of mortality and prevalence of resistance genes. Liu LH; Wang NY; Wu AY; Lin CC; Lee CM; Liu CP J Microbiol Immunol Infect; 2018 Aug; 51(4):565-572. PubMed ID: 28711438 [TBL] [Abstract][Full Text] [Related]
37. In vitro susceptibility and resistance phenotypes in contemporary Citrobacter isolates in a University Hospital in Crete, Greece. Maraki S; Vardakas KZ; Mavromanolaki VE; Kyriakidou M; Spais G; Kofteridis DP; Samonis G; Falagas ME Infect Dis (Lond); 2017 Jul; 49(7):532-539. PubMed ID: 28276281 [TBL] [Abstract][Full Text] [Related]
38. Genetic characterisation of a complex class 1 integron in an NDM-1-producing Citrobacter freundii ST396 clinical strain isolated from a urine sample. Li Z; Lin Y; Lu L; Wang K; Yang L; Li P; Li J; Jia L; Li P; Song H J Glob Antimicrob Resist; 2020 Dec; 23():64-66. PubMed ID: 32818668 [TBL] [Abstract][Full Text] [Related]
39. Whole genome analysis of multidrug-resistant Citrobacter freundii B9-C2 isolated from preterm neonate's stool in the first week. Yap PSX; Ahmad Kamar A; Chong CW; Yap IKS; Teh CSJ J Glob Antimicrob Resist; 2020 Jun; 21():246-251. PubMed ID: 32304769 [TBL] [Abstract][Full Text] [Related]
40. Characterization of mobile genetic elements carrying VIM-1 and KPC-2 carbapenemases in Citrobacter freundii isolates in Madrid. Villa J; Arana DM; Viedma E; Perez-Montarelo D; Chaves F Int J Med Microbiol; 2017 Sep; 307(6):340-345. PubMed ID: 28711315 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]